The short answer is no: dermal fillers do not prevent you from having a facelift. The American Society of Plastic Surgeons has stated plainly that "fillers are safe" and that "there is no real evidence that they in any way impact the outcomes of facelift surgeries at this point." Most board-certified facial plastic surgeons agree that residual filler is not a contraindication for surgical rejuvenation.
But the longer answer is more nuanced. Over the past several years, a growing body of survey data and surgeon-reported experience has made clear that years of filler injections — particularly biostimulatory products like Sculptra and Radiesse — can change how a facelift is planned, how the dissection proceeds, and what the recovery looks like. Some surgeons report increased operative time, more challenging tissue planes, and in rare cases compromised blood supply to facial flaps.
This article walks through what the evidence actually shows, which filler types raise the most concern, and what patients should discuss with their surgeon before proceeding.
What fillers do in tissue over time
Dermal fillers are injected into specific tissue planes — superficial dermis, deep dermis, subcutaneous fat, or supra-periosteal — depending on the product and the treatment goal. What happens next depends heavily on the type of filler.
Hyaluronic acid fillers (Juvéderm, Restylane, Belotero) attract water and integrate into surrounding tissue. Over months, they gradually degrade through enzymatic breakdown and macrophage clearance. Even after the visible volume effect fades, residual HA can persist in tissue for considerably longer than patients assume — sometimes years — particularly with heavily cross-linked formulations placed deep.
Biostimulatory fillers work differently. Sculptra (poly-L-lactic acid, PLLA) and Radiesse (calcium hydroxylapatite, CaHA) do not simply occupy space. They trigger a controlled foreign-body response: macrophages surround the particles, fibroblasts deposit new collagen, and the injected area becomes fibrotic. This is the intended mechanism — it is how these products generate volume that lasts beyond the presence of the carrier gel. But it also means that tissue planes where surgeons later need to operate become scarred and less compliant.
Permanent fillers like Bellafill (polymethylmethacrylate microspheres) create permanent encapsulation. Silicone, though not FDA-approved for aesthetic injection in the US, is still encountered and creates similar permanent tissue changes.
Where facelift dissection meets filler
A facelift — whether deep plane, SMAS flap, or extended SMAS — requires the surgeon to elevate skin and often deeper tissue layers across the midface, lower face, and neck. The critical dissection plane in a deep-plane facelift sits between the SMAS and the overlying subcutaneous fat. This is precisely the plane where midface and cheek filler is most commonly deposited.
When that plane contains years of biostimulatory-induced fibrosis, the normal tissue glide is reduced. The surgeon encounters tissue that does not separate cleanly. Dissection becomes slower and more deliberate, requiring sharper technique rather than blunt spreading. In some cases, the fibrotic tissue creates adhesions that tether the skin to deeper structures, making flap elevation more difficult.
This does not mean the surgery cannot be done. It means the surgeon needs to know about it in advance, plan accordingly, and in some cases modify the approach — choosing a different dissection plane, allocating more operative time, or discussing altered expectations with the patient.
By filler type: least to most concern
Hyaluronic acid fillers — low concern. HA fillers are generally described by surgeons as a "nuisance" rather than an obstacle. They may be encountered during dissection and can be removed if accessible, but they do not typically cause scarring or tissue plane disruption. If necessary, HA fillers can be dissolved with hyaluronidase before surgery, making the tissue easier to work with. The main situation where HA filler causes problems is the tear trough: some surgeons insist on dissolving under-eye filler before blepharoplasty because residual HA in the periorbital area can cause lymphatic blockage and persistent postoperative swelling.
Calcium hydroxylapatite (Radiesse) — moderate concern. Radiesse stimulates collagen production around the CaHA microspheres. While the carrier gel dissipates within months, the fibrotic response persists. Surgeons report encountering Radiesse-related fibrosis in the midface and pre-jowl sulcus — areas that overlap with facelift dissection. Unlike HA fillers, Radiesse cannot be dissolved. That said, the fibrosis is typically localized and manageable for experienced surgeons.
Poly-L-lactic acid (Sculptra) — high concern. Sculptra generates the most surgeon concern among temporary fillers. Because PLLA works by stimulating broad collagen deposition across the treated area, the resulting fibrosis can be diffuse rather than focal. Multiple treatment sessions over years — the typical Sculptra protocol — compound this effect. Surgeons report that Sculptra-treated tissue can feel firm, thickened, and difficult to separate cleanly during facelift dissection.
Permanent fillers (Bellafill, silicone) — highest concern. Permanent fillers create permanent encapsulation and foreign-body granuloma risk. They cannot be removed surgically in most cases, and they permanently alter the tissue architecture. Any surgeon operating on a patient with a history of permanent filler injection needs to anticipate a more complex procedure.
Thread lifts — equal or greater concern. It is worth noting that 74% of surgeons in one survey rated absorbable thread lifts as equally or more concerning than biostimulatory fillers for complicating future facelift surgery. Barbed threads create scar tissue along their entire length, and even after the threads dissolve, the fibrotic tracts remain.
What the surveys and studies show
The evidence base is largely survey-driven, which means it reflects surgeon perception rather than controlled clinical outcomes. That limitation acknowledged, the data is remarkably consistent.
Dr. Christian Subbio conducted an online poll of 114 facial plastic surgeons, reported in Allure, in which 82% of respondents reported finding significant scarring in facelift patients who had previously used Sculptra or other biostimulators. The same poll found that 74% rated thread lifts as equally or more concerning than biostimulators.
A 2023 survey of 156 plastic surgeons conducted through The Aesthetic Society found that more than half claimed repetitive full-face filler injections — specifically Radiesse and Sculptra — make facelifts trickier. Dr. Elizabeth Chance, a plastic surgeon quoted in the survey coverage, stated: "I see it virtually every time I operate."
The same Aesthetic Society survey (PMC9969530) also found that approximately 15.4% of respondents reported compromised flap vascularity during surgery on filler patients — a serious surgical concern, since flap viability depends on adequate perfusion.
On the other side of the evidence, a 2025 study titled "Injectables and Facelifts: Can We Coexist?" (PMC12887548) reviewed outcomes in facelift patients with prior injectable histories, finding that 90% had received HA filler and 55% had received PLLA or CaHA before their surgery.
The American Society of Plastic Surgeons has taken the position, as quoted from Dr. Gregory Dickie and Dr. Sammy Sinno Kim, that fillers do not prevent facelift surgery and that there is no evidence they impact surgical outcomes. Dr. Kim has stated directly: "I do not think residual filler stops you from getting a facelift."
The tension between these two positions — surgeons saying they see real changes in tissue, and professional societies saying the evidence does not show outcome differences — likely reflects the difference between intraoperative experience and postoperative outcome measurement. A surgeon having a harder time dissecting does not necessarily mean the patient ends up with a worse result. But it does mean the surgery is different, and patients deserve to know that.
How surgeons adapt for filler patients
Experienced surgeons who regularly operate on patients with filler histories have developed several strategies:
Pre-operative imaging. Some surgeons use MRI to map residual filler deposits before surgery. This allows them to identify areas of concentrated filler or fibrosis and plan their dissection approach accordingly. MRI is not standard practice, but it is increasingly discussed in the facial plastic surgery literature.
Hyaluronidase pretreatment. For patients with HA filler in areas that will be dissected, many surgeons recommend dissolving the filler with hyaluronidase several weeks before surgery. This clears the tissue planes and makes dissection more straightforward. The standard timing is 2 to 4 weeks preoperatively, allowing any post-dissolution swelling to resolve before the surgical date.
Technique modification. Surgeons may choose a different dissection plane, use sharper rather than blunt dissection in fibrotic areas, or allocate additional operative time. In some cases, the surgical plan shifts from a deep-plane lift to a technique that avoids the most affected tissue planes.
Staged filler removal. For patients with large volumes of HA filler, staged dissolution over several sessions may be recommended rather than dissolving everything at once, to avoid sudden volume loss and tissue collapse.
Honest expectation setting. Surgeons report that filler patients may experience more postoperative swelling, slightly longer recovery, and in some cases less dramatic lifting than patients without filler histories — not because the surgery is less effective, but because the fibrotic tissue may resist repositioning.
What to discuss with your surgeon
If you have a history of filler injections and are considering a facelift, the following conversation points are grounded in the evidence reviewed above:
Disclose your complete injection history. What products were used, where, how many sessions, and when. If you do not remember, your injector's office should have records. This information directly affects surgical planning.
Ask whether pre-operative imaging is appropriate. MRI is not necessary for every patient, but if you have a history of biostimulatory or permanent fillers, your surgeon may want to see what is in the tissue before planning the procedure.
Ask whether dissolving HA filler before surgery is recommended. This is particularly important for midface, cheek, and tear trough filler. For tear trough filler specifically, dissolving before eyelid surgery is increasingly standard practice because of lymphatic concerns.
Understand that biostimulatory fillers cannot be dissolved. Sculptra, Radiesse, and Bellafill will be present in your tissue during surgery. Your surgeon will work around them, but they may affect the procedure.
Ask about expected recovery differences. Filler patients may experience more swelling and a longer initial recovery period. Understanding this in advance prevents unnecessary anxiety during the healing process.
Discuss timing. If dissolving HA filler is recommended, plan for hyaluronidase treatment 2 to 4 weeks before surgery. If you are considering starting filler for the first time and know you want a facelift within a few years, discuss with a board-certified plastic surgeon whether filler is the right interim strategy or whether you should proceed directly to surgery.
Choose your injector with surgery in mind. The surgeons reporting the most difficulty tend to be those operating on patients who received large volumes of biostimulatory filler over many sessions. If you are a candidate for future surgical rejuvenation, discuss this with your injector. Conservative HA-based strategies are easier to reverse or work around than aggressive biostimulatory protocols.
Sources
- Risks and rewards: what to know about dissolving filler. ASPS. https://www.plasticsurgery.org/news/articles/risks-and-rewards-what-to-know-about-dissolving-filler
- Can dermal fillers affect facelift results? ASPS. https://www.plasticsurgery.org/news/blog/can-dermal-fillers-affect-facelift-results
- Getting injectables now could complicate a facelift later. Allure. https://www.allure.com/story/injectables-effects-on-facelifts
- Potential effects of repetitive panfacial filler injections on facelift outcomes: a review. PMC. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC9969530/
- Injectables and facelifts: can we coexist? PMC. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12887548/
- Dermal fillers and facelift surgery: can fillers make a facelift harder? RealSelf. https://www.realself.com/news/dermal-fillers-facelift-surgery
